NIKE (NKE)
(Delayed Data from NYSE)
$89.44 USD
+0.05 (0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $89.44 0.00 (0.00%) 5:02 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$89.44 USD
+0.05 (0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $89.44 0.00 (0.00%) 5:02 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Zacks News
Markets Ease Lower Monday; Nike (NKE) Beats in Q4
by Mark Vickery
The S&P is out of "bear market territory," -19% from its highs, while the Dow is -15% since its high.
Nike (NKE) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nike (NKE) delivered earnings and revenue surprises of 11.11% and 1.39%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Nike (NKE) a Buy Heading Into Q4 Earnings Announcement?
by Bryan Hayes
The stock is in a sustained downtrend and is making a series of lower lows.
NIKE Q4 Earnings Preview: 8th Consecutive EPS Beat in Store?
by Derek Lewis
Year-to-date, it's been a rough stretch for NIKE shares, losing more than 30% in value and extensively underperforming the S&P 500.
Will Supply-Chain Headwinds Continue to Mar NIKE (NKE) in Q4?
by Zacks Equity Research
NIKE's (NKE) Q4 results are expected to reflect the impacts of weakness in Greater China, supply-chain disruptions, higher costs and pulling back operations in Russia.
Nike (NKE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Nike (NKE) closed at $107.34, marking a +0.21% move from the previous day.
Nike (NKE) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nike (NKE) closed the most recent trading day at $120.95, moving -1.99% from the previous trading session.
Nike (NKE) Stock Moves -0.14%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $118.68 in the latest trading session, marking a -0.14% move from the prior day.
Buy Lululemon Stock at a Big Discount and Hold for Years?
by Benjamin Rains
Investors might want to consider buying Lululemon as a long-term retail play because its growth outlook is impressive, as are many of its other fundamentals.
Caleres Inc. (CAL) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Caleres Inc. (CAL) delivered earnings and revenue surprises of 60.98% and 11.20%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
Nike (NKE) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $108.63 in the latest trading session, marking a +0.58% move from the prior day.
Nike (NKE) Stock Moves -0.36%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed at $112.60 in the latest trading session, marking a -0.36% move from the prior day.
Nike (NKE) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nike (NKE) closed at $109.49, marking a -1.55% move from the previous day.
Nike (NKE) Stock Moves -1.85%: What You Should Know
by Zacks Equity Research
Nike (NKE) closed the most recent trading day at $124.70, moving -1.85% from the previous trading session.
The Zacks Analyst Blog Highlights Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service
by Zacks Equity Research
Visa, Walt Disney, Abbott Laboratories, Nike and United Parcel Service have been included in this Analyst Blog.
Top Analyst Reports for Visa, Walt Disney & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), The Walt Disney Company (DIS), and Abbott Laboratories (ABT).
CRI vs. NKE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
Bear of the Day: Foot Locker (FL)
by Madeleine Johnson
Can this athletic shoe retailer win back market share now that its biggest supplier is cutting back product?
Most Indexes End Shortened Week Lower; Twitter Board Meets
by Mark Vickery
The Twitter board is holding an "all hands" meeting to decide the company's next move.
CRI or NKE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRI vs. NKE: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike
by Zacks Equity Research
UnitedHealth Group, Johnson & Johnson, Alibaba Group Holding, Oracle and Nike have been included in this Analyst Blog.
Top Research Reports for UnitedHealth, Johnson & Johnson, & Alibaba
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ), and Alibaba Group Holding Limited (BABA).
2 ETFs & Stocks to Tap the Metaverse Boom
by Sanghamitra Saha
The concept of Metaverse is an emerging one right now. ProShares launched a Metaverse ETF this month, namely VERS. Plus, there is another ETF called Roundhill Ball Metaverse ETF (METV).
Company News for Mar 23, 2022
by Zacks Equity Research
Companies in The News Are: CCL,GDS,NKE,OKTA
Powell Hints at Higher Interest Rate Hikes in Coming Months
by Zacks Equity Research
Powell Hints at Higher Interest Rate Hikes in Coming Months